The skeletal effects of gonadotropin-releasing hormone antagonists: a concise review
NV Mohamad, S Ima-Nirwana… - Endocrine, Metabolic & …, 2021 - ingentaconnect.com
Prolonged treatment with Gonadotropin-Releasing Hormone (GnRH) agonists is known to
induce bone loss among prostate cancer patients. However, evidence on the skeletal effects …
induce bone loss among prostate cancer patients. However, evidence on the skeletal effects …
The Skeletal Effects of Gonadotropin-Releasing Hormone Antagonists: A Concise Review
NV Mohamad, S Ima-Nirwana, KY Chin… - … Metabolic & Immune …, 2021 - ingentaconnect.com
Midsaggital section of brain showing central neural pathways receiving baroreceptor inputs
via the IX and X nerves, and the effects of VP on arterial baroreflex control of SNS. NTS …
via the IX and X nerves, and the effects of VP on arterial baroreflex control of SNS. NTS …
The Skeletal Effects of Gonadotropin-Releasing Hormone Antagonists: A Concise Review.
NV Mohamad, S Ima-Nirwana… - Endocrine, Metabolic & …, 2021 - europepmc.org
Prolonged treatment with Gonadotropin-Releasing Hormone (GnRH) agonists is known to
induce bone loss among prostate cancer patients. However, evidence on the skeletal effects …
induce bone loss among prostate cancer patients. However, evidence on the skeletal effects …
The Skeletal Effects of Gonadotropin-Releasing Hormone Antagonists: A Concise Review
NV Mohamad, S Ima-Nirwana… - … , metabolic & immune …, 2021 - pubmed.ncbi.nlm.nih.gov
Prolonged treatment with Gonadotropin-Releasing Hormone (GnRH) agonists is known to
induce bone loss among prostate cancer patients. However, evidence on the skeletal effects …
induce bone loss among prostate cancer patients. However, evidence on the skeletal effects …